Axon Enterprise, INC Form 4 insider transactions

NASDAQ
Axon Enterprise Director Caitlin Kalinowski filed an amended Form 4 to correct details of common stock sales on May 13 and May 14, 2025, previously misreported due to a broker error.
NASDAQ
Axon Enterprise CEO Patrick W. Smith sold 9,900 shares of common stock on December 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Axon Enterprise President Joshua Isner sold 20,000 shares of common stock for approximately $11 million through a pre-arranged trading plan.
NASDAQ
Axon Enterprise's Chief Accounting Officer, Jennifer H. Mak, sold 894 shares of common stock for $550 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise Director Jeri Williams sold 100 shares of common stock for approximately $55,065 in a pre-scheduled transaction.
NASDAQ
Axon Enterprise's COO and CFO, Brittany Bagley, disposed of 16,151 shares of common stock to cover tax liabilities related to RSU vesting.
NASDAQ
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, disposed of 747 shares of common stock to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
Axon Enterprise President Joshua Isner reported the sale of 36,787 shares of common stock, including shares withheld for tax obligations and sales under a pre-arranged trading plan.
NASDAQ
Axon Enterprise's Chief Accounting Officer, Jennifer H. Mak, reported the disposition of common stock primarily for tax obligations and a planned sale.
NASDAQ
Axon Enterprise's CPO & CTO, Jeffrey C. Kunins, disposed of common stock through tax withholdings and sales following restricted stock unit vesting, executed under a Rule 10b5-1 plan.
NASDAQ
Axon Enterprise, Inc. President Joshua Isner received 67,910 shares of common stock after performance conditions for restricted stock units were certified.
NASDAQ
Axon Enterprise's CPO & CTO, Jeffrey C. Kunins, was awarded 20,618 performance-based restricted stock units after performance conditions were met.
NASDAQ
Axon Enterprise CEO Patrick W. Smith was granted 97,015 shares of common stock as part of a performance award, increasing his beneficial ownership to over 3.1 million shares.
NASDAQ
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, acquired 15,810 shares of common stock through the vesting of performance-based restricted stock units.
NASDAQ
Axon's Chief Accounting Officer, Jennifer H. Mak, reported the vesting of performance-based restricted stock units and subsequent tax-related share disposition.
NASDAQ
AXON Enterprise's COO and CFO, Brittany Bagley, increased her beneficial ownership by 30,560 shares following the vesting of performance-based restricted stock units.
NASDAQ
Axon Enterprise's COO and CFO, Brittany Bagley, reported the sale of 2,500 shares of common stock at $610 per share.
NASDAQ
Axon Enterprise CEO Patrick W. Smith disposed of 9,096 shares of common stock on November 7, 2025, through a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported the vesting of performance-based restricted stock units and subsequent tax-related share disposition.
NASDAQ
AXON Enterprise CEO Patrick W. Smith sold 9,640 shares of common stock on October 7, 2025, through a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Axon Enterprise's COO and CFO, Brittany Bagley, reported the sale of 4,900 common shares and a tax-related disposition of 14,430 shares, primarily executed under a Rule 10b5-1 trading plan.
NASDAQ
AXON's Chief Accounting Officer, Jennifer H. Mak, sold 77 shares of common stock for $760 per share on September 15, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
AXON Enterprise's COO and CFO, Brittany Bagley, sold 870 shares of common stock for approximately $773.25 per share under a pre-arranged trading plan.
NASDAQ
AXON Enterprise Director Jeri Williams sold 100 shares of common stock for a weighted average price of $752.5434 on September 11, 2025, as part of a pre-arranged Rule 10b5-1 plan.
NASDAQ
Axon Enterprise CEO Patrick W. Smith sold 10,500 shares of common stock for approximately $7.8 million through a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Axon Enterprise Director Hadi Partovi received a grant of 100 restricted stock units, fully vested, with a transaction date of August 29, 2025.
NASDAQ
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported a planned disposition of 749 shares of common stock on September 2, 2025, to cover tax liabilities from restricted stock unit vesting.
NASDAQ
Axon Enterprise, Inc. Director Jeri Williams received a grant of 100 restricted stock units, which vested immediately, as reported in a recent SEC Form 4 filing.
NASDAQ
Axon Enterprise's Chief Accounting Officer, Jennifer Mak, reported the disposition of 160 shares of common stock, including shares for tax liabilities and under a 10b5-1 plan.
NASDAQ
Axon Enterprise, Inc. Director Todd Morgenfeld was granted 336 time-vested restricted stock units, set to vest starting August 2026.